Phase I Clinical Trial of RAD001 in Combination With CP-751,871 in Patients With Advanced Sarcomas and Other Malignant Neoplasms.
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2013
At a glance
- Drugs Everolimus (Primary) ; Figitumumab (Primary)
- Indications Sarcoma; Solid tumours
- Focus Adverse reactions
- 24 Feb 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 24 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2012 Actual patients number is 21 as reported by ClinicalTrials.gov.